Gastrointestinal microbiome and cholelithiasis: Current status and perspectives

World J Gastroenterol. 2023 Mar 14;29(10):1589-1601. doi: 10.3748/wjg.v29.i10.1589.

Abstract

Cholelithiasis is a common digestive disease affecting 10% to 15% of adults. It imposes significant global health and financial burdens. However, the pathogenesis of cholelithiasis involves several factors and is incompletely elucidated. In addition to genetic predisposition and hepatic hypersecretion, the pathogenesis of cholelithiasis might involve the gastrointestinal (GI) microbiome, consisting of microorganisms and their metabolites. High-throughput sequencing studies have elucidated the role of bile, gallstones, and the fecal microbiome in cholelithiasis, associating microbiota dysbiosis with gallstone formation. The GI microbiome may drive cholelithogenesis by regulating bile acid metabolism and related signaling pathways. This review examines the literature implicating the GI microbiome in cholelithiasis, specifically gallbladder stones, choledocholithiasis, and asymptomatic gallstones. We also discuss alterations of the GI microbiome and its influence on cholelithogenesis.

Keywords: Bile acid; Bile microbiome; Cholesterol gallstone; Common bile duct stone; Gallstone; Gastrointestinal microbiome.

Publication types

  • Review

MeSH terms

  • Bile Acids and Salts / metabolism
  • Choledocholithiasis*
  • Gastrointestinal Microbiome*
  • Humans
  • Liver* / metabolism

Substances

  • keto bile acids
  • Bile Acids and Salts